Revvityブログ
発見から治療までのイノベーションを促進
 
     
    
            
        Latest
      
    
    Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.
Functional Genomic Screening 
October 30, 2025  -  3  min read
       
      Physiological Model Solutions, Automation
        Overcoming throughput, standardization, and analysis challenges for human midbrain organoids.
            May 10, 2024 -
            2 min read
          
          
         
       
      Physiological Model Solutions, Disease Research, Small Molecule Drug Discovery
        Seeing through the dark: high-content imaging of 3D cell models.
            May 10, 2024 -
            1 min read
          
          
         
      Small Molecule Drug Discovery
        Adopting no-wash immunoassays for higher throughput.
            May 10, 2024 -
            1 min read
          
          
         
      Small Molecule Drug Discovery
        Advances in high-content screening: navigating the data deluge.
            May 10, 2024 -
            2 min read
          
          
         
      Small Molecule Drug Discovery
        Strategies for highly efficient gene editing and modulation.
            May 10, 2024 -
            2 min read
          
          
         
      Small Molecule Drug Discovery
        Radiometric detection for precise and efficient molecular quantitation.
            May 6, 2024 -
            1 min read
          
          
         
       
      Biobanking
        10 reasons to automate your nucleic acid separation workflow.
            April 30, 2024 -
            2 min read
          
          
         
      Cell and Gene Therapy, Biologics, Cancer
        6 factors for improving cell counting results.
            April 30, 2024 -
            2 min read
          
          
         
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                  